Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XASEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XASEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XASECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XASECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XASEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XASEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XASENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XASENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.512EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.512EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.512ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.512ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.512EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.512EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.512ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.512ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.349EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-19758.7South Korea
B.1.1.349EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.349ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-25097.5Germany
B.1.1.349ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.349EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.349EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.349ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.349ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.265EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.265EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.265ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.265ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.265EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.265EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.265ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.265ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.401EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.401EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.401ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.401ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.401EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.401EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.401ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.401ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used